Navigation Links
2014 Analysis of the European Molecular Diagnostics Market: Segment Forecasts and Supplier Shares
Date:11/14/2013

NEW YORK, Nov. 14, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

2014 Analysis of the European Molecular Diagnostics Market: Segment Forecasts and Supplier Shares

http://www.reportlinker.com/p01866553/2014-Analysis-of-the-European-Molecular-Diagnostics-Market-Segment-Forecasts-and-Supplier-Shares.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

This new 970-page comprehensive five-country report from Venture Planning Group is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

The $4.5 billion molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of and cost-effective automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next five years.

Table of Contents I. Introduction

II. Worldwide Technology and Market Overview

A. DNA Sequencing

B. DNA and RNA Probes Technology

C. Detection Technologies

D. Instrumentation Review

E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip

F. Pharmacogenomics

G. Major Applications

III.

France

IV. Germany

V. Italy

VI. Spain

VII

.

U.K.

VIII. Major Product Development Opportunities

IX. Design Criteria for Decentralized Testing Products

X. Alternative Market Penetration Strategies

XI. Potential Market Entry Barriers and Risks

XII. Competitive Assessments

XIII. Appendix

Contains 970 pages and 75 tables

IntroductionWorldwide Market And Technology OverviewA. DNA Sequencing1. Introduction2. Sequencing Methods3. Autoradiography4. The Human Genome Project5. Sequencing Automation6. Image Scanners7. Fluorescent Detection8. Gene Profiling9. Gene Expression10. Polymorphism Screening11. Protein Interaction NetworksB. DNA And RNA Probe Technology1. Basic Principles2. Probe Preparation3. The DNA Probe Testa. Sample Preparationb. Hybridizationc. Separationd. Detection/Measurement4. Test Formatsa. Filter Hybridizationb. Southern Blotc. Northern Blotd. In Situ Hybridizatione. Others5. Labeling Techniques6. Amplification MethodsO Polymerase Chain Reaction- Temperature Cyclers - PCR Variations* Immuno-PCR* QC-PCR* DAP-PCRO Strand Displacement ActivationO TMAO Ligase Chain ReactionO Branched DNA- Hybridization Protection Assay O Nucleic-Acid Sequence-Based AmplificationO Self-Sustained Sequence ReplicaseO Others- Ampliprobe- CAR- CAS- CPT- Dendritic Polymer Technology- ISO-CR- LAT- Probe Networks- RAMP- Repair Chain Reaction- Rolling Circles- Sequence Independent Gene Amplification- Sequence Initiation Reaction- SISPA- Solid Phase AmplificationC. Detection Technologies1. Radioactive Methodsa. Overviewb. Major IsotopesO P-32O S-35O H-3O I-125 2. Non-Isotopic Methodsa. Enzymatic Labelsb. Chemical LabelingO Indirect Chemical LabelingO Direct Chemical Labeling c. Fluorescenced. Chemiluminescencee. Electrical ConductivityD. Instrumentation Review1. Abbott LCx2. Beckman Coulter/Biomek FK3. Becton Dickinson SDA4. Bio-Rad GeneScope5. Gen-Probe Tigris6. Roche Cobas Amplicor7. Tecan LS SeriesE. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip- Liquid Transportation and Mixing- Separation- Reaction- DetectionF. PharmacogenomicsG. Major Applications1. Microbiology/Infectious Diseasesa. Overviewb. Major Infectious Diseases* AIDSO Structure and CompositionO ClassificationO AIDS OriginsO Animal Lentivirus SystemsO Virus ReceptorsO HIV Infections in Humans- Pathogenesis and PathologyO CD4T Lymphocytes and Memory CellsO Monocytes and MacrophagesO Lymphoid OrgansO Neural CellsO Viral Coinfections- Clinical FindingsO Plasma Viral Load

O Pediatric AIDS

- Neurologic Disease

- Opportunistic Infections

- Cancer

O Immunity

- Virus Isolation

- Serology

- Viral Nucleic Acid/Antigen Detection

O Epidemiology

- Worldwide Spread of AIDS

- United States

- Routes of Transmission

O DNA Probes

- Overview

- Quantitative PCR

- In Situ PCR

- Needed Improvements

O Viral Load/Drug Resistance Testing

O Genotype and Phenotype Testing

O Blood Banking Considerations

* Adenovirus

O Background

O Diagnostic Tests

O Vaccines and Drugs

O Adeno-Associated Viruses (AAV)

* Anthrax/Bacillus Anthracis

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Babesiosis

O Background

* BEA and Other Bartonella Diseases

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Chagas Disease

O Background

* Campylobacter

O Background

O Diagnostic Tests

- Culture Identification

O Vaccines and Drugs

* Chlamydia

O Background

- Chlamydia psittaci

- Chlmaydia pneumoniae

- Chlamydia trachomatis

O Diagnostic Tests

O Vaccines and Drugs

* Creutzfeldt-Jakob's Disease

O Background

O Blood Transmission

O Diagnostic Tests

O Major Commercial and Academic Players

- Bayer

- Disease Sciences/Bio Tec Global

- Imperial College School of Medicine

- Ortho-Clinical Diagnostics

- Pall

- ProMetic Life Sciences

- Proteome Sciences/Idexx

- Q-One Biotech

- Serono

- U.S. Agricultural Research Service

O Drugs

O Vaccines

* Cytomegalovirus

O Background

- Chorioretinitis

- Gastrointestinal

- Central Nervous System Disease

O Diagnostic Tests

O Vaccines and Drugs

* Ebola Virus

O Background

- Epidemiology

- Clinical Syndromes

O Diagnostic Tests

O Vaccines and Drugs

* EchoVirus

O Background

- Acute Aseptic Meningitisis

- Encephalitis

- Exanthems

- Respiratory Disease

- Myopericarditis

- Neonatal Infections

O Diagnostic Tests

O Vaccines and Drugs

* Encephalitis

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Enteroviruses

O Background

O Diagnostic Tests

- Viral Isolation and Identification

- Antibody Tests

O Vaccines and Drugs

* Epstein-Barr Virus

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Gonorrhea

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Hepatitis

O Hepatitis A

O Hepatitis B

- Structure and Composition

- Replication

O Hepatitis C

O Hepatitis D (Delta)

O Hepatitis E

O Hepatitis G

O Hepatitis Infections Pathology

O Clinical Findings

O Laboratory Tests

- Hepatitis A

- Hepatitis B

- Hepatitis C

- Hepatitis D

- Hepatitis E

O Virus-Host Immune Reactions

O Epidemiology

- Hepatitis A

- Hepatitis B

- Hepatitis C

- Hepatitis D (Delta)

O Vaccines and Drugs

* Herpes Simplex Virus

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Legionella

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Lyme Disease

O Background

- Clinical Description

- Clinical Case Definition

- Laboratory Criteria for Diagnosis

- Case Classification

O Diagnostic Tests

O Vaccines and Drugs

* Malaria

* Mycoplasma

O Background

- Ureaplasma Urealyticum & Mycoplasma

Hominis

O Diagnostic Tests

O Vaccines and Drugs

* Papillomaviruses/HPV

O Background

- HPV in Cancer

- Cervical Neoplasm

O Diagnostic Tests

O Vaccines and Drugs

- Prevention

* Parvovirus B19

O Background

- Microbiology

- Epidemiology

- Clinical Syndromes

- Erythema Infectiosum (Slapped Cheek)

- Adult Polyarthropathy

- Transient Aplastic Crisis

- Transient Pancytopenia

- Red Cell Aplasia in Immunocompromised

- Perinatal Infections

O Diagnostic Test

O Vaccines and Drugs

* Pneumonia

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Polyomaviruses

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Salmonellosis

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Shigellosis

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Streptococci

O Background

O Diagnostic Tests

O Vaccines and Drugs

- Group A Streptococci

- Group B Streptococci

* Toxoplasmosis

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Tuberculosis

O Background

O Diagnostic Tests

- Microscopic Characteristics

- Cultural Characteristics

- Skin Tests

- MDRTB

O Vaccines and Drugs

* West Nile Virus

O Background

- Clinical Syndromes

O Diagnostic Tests

O Vaccines and Drugs

* Yersinia

O Background

O Diagnostic Tests

O Vaccines and Drugs

c. Antibiotic Susceptibility

2. Cancer Testing

a. Overview

b. Major Cancer Types

* Prostate

* Lung

* Colon and Rectum

* Breast

* Skin

* Uterine

* Leukemia

* Oral

c. Oncogenes

O Abl/abl-bcr

O AIB1

O BCL-2

O BRCA1

O CD44

O C-fos

O C-myb

O C-myc

O CYP17

O Erb-B

O HPC1

O N-myc

O P40

O P51

O P53

O PIK3CA

O PTI-1

O Ras

O Reg

O Sis

O Src

3. Genetic Diseases

a. Overview

b. Nucleic Acid Amplification

c. Chromosome Imaging

d. Genomics Technologies

e. Proteomics Technologies

f. Current Pharmacogenomic Tests

g. Future Pharmacogenomic Testing

h. Major Diseases

* Achondroplasia

* Autosomal Dominant Polycystic Kidney

Disease

* Cancer

* Cosmetogenomics

* Cystic Fibrosis

* Down's Syndrome

* Duchenne and Becker Muscular Dystrophy

* Factor V (Leiden)

* Factor IX Deficiency

* Fragile X Syndrome

* Heart Disease

* Hemochomatosis

* Hemophilia

* Huntington's Disease

* Maternal-Fetal Incompatibility

* Multiple Endocrine Neoplasia

* Phenylketonuria (PKU)

* Polycystic Kidney Disease (PKD)

* Prenatal Screening

* Retinitis Pigmentosa

* Retinoblastoma

* Sickle Cell Anemia

* Spinal Muscular Atrophy

* Vitamin B12 Metabolism

i. Social Issues and Concerns

4. Forensic Testing

a. Overview

b. Multilocus and Single Locus Probes

* Multilocus Probes

* Single Locus Probes

* PCR and RFLP

c. The FBI

d. DNA Profile Data Banks

* U.S.A.

* U.K.

e. Judicial Implementation

f. Major Crime Categories

g. Factors Contributing to the DNA Probe

Market Expansion

* Technology Availability

* Use of Hair as Evidence

h. Wildlife Forensics

5. Paternity Testing/HLA Typing

6. Other Applications

a. Disease Susceptibility Testing

b. Cardiovascular Diseases

c. Diabetes

d. Alzheimer's Disease

e. Periodontal Disease

f. Plasma Purification

g. Organ Transplantation

h. Water Contamination

i. Other

H. Competing/complementing Technologies

1. Monoclonal Antibodies/Immunoassays

2. RNA Probes

3. Two-Dimensional Electrophoresis

4. Flow Cytometry

FranceA. Executive SummaryB. Business EnvironmentC. Market StructureD. Market Size, Growth And Major Suppliers' Sales And Market SharesGermanyA. Executive SummaryB. Business EnvironmentC. Market StructureD. Market Size, Growth And Major Suppliers'Sales And Market SharesItalyA. Executive SummaryB. Business EnvironmentC. Market StructureD. Market Size, Growth And Major Suppliers'Sales And Market SharesSpainA. Executive SummaryB. Business EnvironmentC. Market StructureD. Market Size, Growth And Major Suppliers'Sales And Market SharesU.K.A. Executive SummaryB. Business EnvironmentC. Market StructureD. Market Size, Growth And Major Suppliers'Sales And Market SharesMajor Product Development OpportunitiesA. InstrumentationB. Reagent Kits and Test Systems/panelsC. Computers, Software and AutomationD. Auxiliary Products Design Criteria For Decentralized Testing ProductsAlternative Market Penetration StrategiesA. Internal DevelopmentB. Collaborative ArrangementsC. University ContractsD. Distribution Strategies For Decentralized Testing Markets1. Marketing Approaches2. Product Complexity3. Customer Preference4. Established Suppliers5. Emerging Suppliers6. Major Types Of Distributors7. Market SegmentationPotential Market Entry Barriers And RisksA. Market MaturityB. Cost ContainmentC. CompetitionD. Technological Edge And LimitationsE. Patent ProtectionF. Regulatory ConstraintsG. Decentralized Testing Market Challenges

Competitive Profiles

- Abbott- Affymetrix- Agilent- Applied Gene Technologies- Beckman Coulter/Danaher- Becton Dickinson- Biokit - BioMerieux- Bio-Rad- Biotest- Caliper- Cepheid- Decode - Diadexus - Eiken- Enzo- Exact Sciences- Fujirebio- Gen-Probe- Hologic- Illumina- Innogenetics/Solvay- Kreatech- Li-Cor Biosciences- Life Technologies- Monogram Biosciences- Myriad Genetics- Nanogen/Elitech- Novartis- Nuvelo- Orchid CellMark- Ortho-Clinical Diagnostics- Proteome Sciences- Qiagen- Roche- Scienion- Sequenom- Shimadzu- Siemens- Sierra Molecular- Takara Bio- Tecan Group AppendixesAppendix I: Major Universities and ResearchCentersDeveloping Molecular Diagnostic TechnologyAppendix II: Glossary of TermsAppendix III: Currency Exchange Rates

List of Tables

Major Companies Developing or Marketing AIDS MolecularDiagnostic And Other Direct Identification TestsMajor Companies Developing or Marketing AdenovirusMolecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing CampylobacterMolecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing ChlamydiaMolecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing CMV MolecularDiagnostic And Other Direct Identification TestsMajor Companies Developing or Marketing EBV MolecularDiagnostic And Other Direct Identification TestsMajor Companies Developing or Marketing GonorrheaMolecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing HepatitisMolecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing HerpesMolecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing LegionellaMolecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing LymeDisease Molecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing MycoplasmaMolecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing PapillomaVirus Molecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing PneumoniaMolecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing SalmonellaMolecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing ShigellaMolecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing Streptococci Molecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing ToxoplasmosisMolecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing TuberculosisMolecular Diagnostic And Other DirectIdentification TestsOncogenes Potential Application in Cancer DiagnosisMajor Companies Developing or Marketing CancerMolecular Diagnostic TestsMajor Companies Developing or Marketing MolecularDiagnostic Test For Genetic DiseasesSummary Table France, Molecular Diagnostic Test VolumeAnd Sales Forecast by Major ApplicationFrance, Laboratories Performing DNA SequencingBy Market SegmentFrance, Molecular Diagnostics Market PotentialLaboratory Universe by Market SegmentFrance, Molecular Diagnostic Test Volume ForecastBy Major Application

France, Major Infectious Disease Molecular

Diagnostics Test Volume Forecast

France, Infectious Disease Screening

NAT Volume Forecast

France, Molecular Diagnostics Market Forecast

By Major Application

France, Infectious Disease Screening NAT Reagent

Market Forecast by Test

France, Molecular Diagnostics Market

By Major Supplier

France, HIV/Hepatitis NAT Market Reagent Sales

By Major Supplier

Summary Table Germany, Molecular Diagnostics Test Volume

And Sales Forecast by Major Application

Germany, Laboratories Performing

DNA Sequencing by Market Segment

Germany, Molecular Diagnostics Market

Potential Laboratory Universe by Market Segment

Germany, Molecular Diagnostics Test Volume Forecast

By Major Application

Germany, Major Infectious Disease MolecularDiagnostics Test Volume ForecastGermany, Infectious Disease ScreeningNAT Volume ForecastGermany, Molecular Diagnostics Market ForecastBy Major Application Germany, Infectious Disease ScreeningNAT Reagent Market Forecast by Test Germany, Molecular Diagnostics Market by Major Supplier Germany, HIV/Hepatitis NAT Market ReagentSales by Major SupplierSummary Table Italy, Molecular Diagnostics Test VolumeAnd Sales Forecast by Major Application Italy, Laboratories PerformingDNA Sequencing by Market Segment Italy, Molecular Diagnostics Market PotentialLaboratory Universe by Market SegmentItaly, Molecular Diagnostics Test Volume ForecastBy Major Application Italy, Major Infectious Disease MolecularDiagnostics Test Volume ForecastItaly, Infectious Disease Screening NAT Volume ForecastItaly, Molecular Diagnostics Market ForecastBy Major Application Italy, Infectious Disease ScreeningNat Reagent Market Forecast by Test Italy, Molecular Diagnostics MarketBy Major SupplierItaly, HIV/Hepatitis NAT MarketBy Major SupplierSummary Table Spain, Molecular Diagnostics Test VolumeAnd Sales Forecast by Major Application Spain, Laboratories PerformingDNA Sequencing by Market Segment Spain, Molecular Diagnostics Market, PotentialLaboratory Universe by Market SegmentSpain, Molecular Diagnostics Test VolumeForecast by Major Application

Spain, Major Infectious Disease Molecular

Diagnostics Test Volume Forecast

Spain, Infectious Disease Screening

NAT Volume Forecast

Spain, Molecular Diagnostics Market Forecast

By Major Application

Spain, Infectious Disease Screening Nat

Reagent Market Forecast by Test

Spain, Molecular Diagnostics Market

By Major Supplier

Spain, HIV/Hepatitis NAT Market ReagentSales by Major SupplierSummary Table U.K., Molecular Diagnostics Test VolumeAnd Sales Forecast by Major Application U.K., Laboratories PerformingDna Sequencing by Market Segment U.K., Molecular Diagnostics Market PotentialLaboratory Universe by Market SegmentU.K., Molecular Diagnostics Test Volume ForecastBy Major Application U.K., Major Infectious Disease MolecularDiagnostics Test Volume ForecastU.K., Infectious Disease Screening NAT Volume ForecastU.K., Molecular Diagnostics Market ForecastBy Major Application U.K., Infectious Disease Screening NAT ReagentMarket Forecast by Test U.K., Molecular Diagnostics Market by Major SupplierTo order this report: 2014 Analysis of the European Molecular Diagnostics Market: Segment Forecasts and Supplier Shares http://www.reportlinker.com/p01866553/2014-Analysis-of-the-European-Molecular-Diagnostics-Market-Segment-Forecasts-and-Supplier-Shares.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

 


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved


Related biology technology :

1. Global Aptamers Market Technology Trend Analysis Market Report 2013-2018: Therapeutics, Diagnostics, Biosensors, Biomarker/Drug Discovery & Applications
2. Global Positron Emission Tomography Market 2012-2016: Industry Analysis, Size, Share, Growth, Trends and Forecast New Research Report Available at MarketResearchReports.biz
3. Acquisitions, Project Announcements & Trend Analysis News for Oxygen Biotherapeutics, Glu Mobile, Cisco Systems, Barrick Gold, CVS Caremark
4. Science Group Says Article on DNA Barcode Analysis of Herbs Is Flawed, Contains Errors, Creates Confusion, and Should Be Retracted
5. Analysis of Global Biochips Industry, 2012-2018
6. Global In Vitro Fertilization Market 2012-2016: Industry Analysis, Size, Share, Growth, Trends and Forecast New Research Report Available at MarketResearchReports.biz
7. Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis
8. Commercial (Conventional And Biotech/GM) Seeds Market For Soybean, Corn, Cotton And Others - Global Industry Analysis 2012 - 2018
9. Silane Coupling Agent Industry 2013 Global & China Development Trend Analysis in a New Study at DeepResearchReports.com
10. SNP Genotyping and Analysis Market is Expected to Reach to USD 9.5 Billion Globally by 2019: Transparency Market Research
11. Computer-Aided Image Analysis Aims to Offer ‘Second Opinion’ in Breast Tumor Diagnosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... AVIV, Israel , May 24, 2016   MedyMatch ... providing physicians with artificial intelligence, real-time decision support tools in ... to present at the 2016 Israeli Advanced Technology Industries (IATI) ... of Israel,s 15th National Life Sciences ... 26th at the David Intercontinental Hotel in Tel ...
(Date:5/24/2016)... ... 24, 2016 , ... Media Cybernetics, global image analysis leader, ... branding reflects a results-driven revitalization for a company with a renewed focus on ... a crisp, refreshed logo and a new web presence. , “I believe that ...
(Date:5/23/2016)... ... May 23, 2016 , ... PrecisionAg® Media has released ... and Beyond. The paper outlines the key trends that are creating both opportunities ... witnessed a lot of highs and lows as the precision agriculture market has ...
(Date:5/23/2016)... May 23, 2016 Oxitec CEO ... at 10:15 a.m. ET before the United States House ... engineered mosquitos can play in controlling the spread of the ... Zika virus.      (Logo: http://photos.prnewswire.com/prnh/20150630/227348 ) ... with a self-limiting gene. Trials in Brazil ...
Breaking Biology Technology:
(Date:5/3/2016)... May 3, 2016  Neurotechnology, a provider of ... MegaMatcher Automated Biometric Identification System (ABIS) , a ... projects. MegaMatcher ABIS can process multiple complex biometric ... combination of fingerprint, face or iris biometrics. It ... and MegaMatcher Accelerator , which have ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
(Date:4/14/2016)... AVIV, Israel , April 14, 2016 ... Behavioral Authentication and Malware Detection, today announced the appointment ... already assumed the new role. Goldwerger,s leadership ... BioCatch, on the heels of the deployment of its ... addition, BioCatch,s behavioral biometric technology, which discerns unique cognitive ...
Breaking Biology News(10 mins):